These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39087522)

  • 1. Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C.
    Hei Z; Yang S; Ouyang G; Hanna J; Lepoivre M; Huynh T; Aguinaga L; Cassinat B; Maslah N; Bourge M; Golinelli-Cohen MP; Guittet O; Vallières C; Vernis L; Fenaux P; Huang ME
    Br J Haematol; 2024 Sep; 205(3):1017-1030. PubMed ID: 39087522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer.
    Hatem E; Azzi S; El Banna N; He T; Heneman-Masurel A; Vernis L; Baïlle D; Masson V; Dingli F; Loew D; Azzarone B; Eid P; Baldacci G; Huang ME
    J Natl Cancer Inst; 2019 Jun; 111(6):597-608. PubMed ID: 30779852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer.
    Hatem E; Azzi S; El Banna N; He T; Heneman-Masurel A; Vernis L; Baïlle D; Masson V; Dingli F; Loew D; Azzarone B; Eid P; Baldacci G; Huang ME
    J Natl Cancer Inst; 2018 Nov; ():. PubMed ID: 30462268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia.
    Khanim FL; Hayden RE; Birtwistle J; Lodi A; Tiziani S; Davies NJ; Ride JP; Viant MR; Gunther UL; Mountford JC; Schrewe H; Green RM; Murray JA; Drayson MT; Bunce CM
    PLoS One; 2009 Dec; 4(12):e8147. PubMed ID: 19997560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway.
    Tauchi T; Moriya S; Okabe S; Kazama H; Miyazawa K; Takano N
    PLoS One; 2024; 19(7):e0307662. PubMed ID: 39052583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.
    Österroos A; Kashif M; Haglund C; Blom K; Höglund M; Andersson C; Gustafsson MG; Eriksson A; Larsson R
    Biochem Pharmacol; 2016 Oct; 118():40-49. PubMed ID: 27565890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and Bim.
    Dai Y; Chen S; Wang L; Pei XY; Kramer LB; Dent P; Grant S
    Br J Haematol; 2011 Apr; 153(2):222-35. PubMed ID: 21375523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
    Herrmann H; Blatt K; Shi J; Gleixner KV; Cerny-Reiterer S; Müllauer L; Vakoc CR; Sperr WR; Horny HP; Bradner JE; Zuber J; Valent P
    Oncotarget; 2012 Dec; 3(12):1588-99. PubMed ID: 23249862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.
    Noguera NI; Pelosi E; Angelini DF; Piredda ML; Guerrera G; Piras E; Battistini L; Massai L; Berardi A; Catalano G; Cicconi L; Castelli G; D'Angiò A; Pasquini L; Graziani G; Fioritoni G; Voso MT; Mastrangelo D; Testa U; Lo-Coco F
    Oncotarget; 2017 May; 8(20):32550-32565. PubMed ID: 28427227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
    Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin C promotes anti-leukemia of DZNep in acute myeloid leukemia.
    Long B; Shan Y; Sun Y; Wang T; Li X; Huang K; Zhang W; He Y; Wen R; Li Y; Mai Y; Feng Y; Zhang T; Kang B; Zhang C; Zhu Y; Gu J; Liu J; Zhang X; Pan G
    Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166357. PubMed ID: 35143932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic effects of high concentrations of sodium ascorbate on human myeloid cell lines.
    Mastrangelo D; Massai L; Lo Coco F; Noguera NI; Borgia L; Fioritoni G; Berardi A; Iacone A; Muscettola M; Pelosi E; Castelli G; Testa U; Di Pisa F; Grasso G
    Ann Hematol; 2015 Nov; 94(11):1807-16. PubMed ID: 26264692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peperomin E and its orally bioavailable analog induce oxidative stress-mediated apoptosis of acute myeloid leukemia progenitor cells by targeting thioredoxin reductase.
    Wang X; Gao M; Zhang J; Ma Y; Qu W; Liang J; Wu H; Wen H
    Redox Biol; 2019 Jun; 24():101153. PubMed ID: 30909158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.
    Pei S; Minhajuddin M; Callahan KP; Balys M; Ashton JM; Neering SJ; Lagadinou ED; Corbett C; Ye H; Liesveld JL; O'Dwyer KM; Li Z; Shi L; Greninger P; Settleman J; Benes C; Hagen FK; Munger J; Crooks PA; Becker MW; Jordan CT
    J Biol Chem; 2013 Nov; 288(47):33542-33558. PubMed ID: 24089526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.
    Karsa M; Kosciolek A; Bongers A; Mariana A; Failes T; Gifford AJ; Kees UR; Cheung LC; Kotecha RS; Arndt GM; Haber M; Norris MD; Sutton R; Lock RB; Henderson MJ; Somers K
    Br J Cancer; 2021 Jul; 125(1):55-64. PubMed ID: 33837299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.
    Sanjiv K; Calderón-Montaño JM; Pham TM; Erkers T; Tsuber V; Almlöf I; Höglund A; Heshmati Y; Seashore-Ludlow B; Nagesh Danda A; Gad H; Wiita E; Göktürk C; Rasti A; Friedrich S; Centio A; Estruch M; Våtsveen TK; Struyf N; Visnes T; Scobie M; Koolmeister T; Henriksson M; Wallner O; Sandvall T; Lehmann S; Theilgaard-Mönch K; Garnett MJ; Östling P; Walfridsson J; Helleday T; Warpman Berglund U
    Cancer Res; 2021 Nov; 81(22):5733-5744. PubMed ID: 34593524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of JAK2/STAT3 intensifies the anti-tumor activity of arsenic trioxide in acute myeloid leukemia cells: Novel synergistic mechanism via the mediation of reactive oxygen species.
    Mesbahi Y; Zekri A; Ghaffari SH; Tabatabaie PS; Ahmadian S; Ghavamzadeh A
    Eur J Pharmacol; 2018 Sep; 834():65-76. PubMed ID: 30012499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
    Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
    Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells.
    Walsby EJ; Lazenby M; Pepper CJ; Knapper S; Burnett AK
    Br J Haematol; 2013 Apr; 161(1):57-67. PubMed ID: 23356405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.